89 results on '"Loghin, Monica"'
Search Results
52. INNV-15. ANALYSIS OF CHALLENGES TO ACCRUAL IN CLINICAL TRIALS FOR NEWLY DIAGNOSED GLIOBLASTOMA
53. Phase 1 lead‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma
54. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer
55. Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.
56. A phase I/II clinical trial of autologous CMV-specific cytotoxic T cells (CMV-TC) for glioblastoma: Dose escalation results.
57. The natural course of hypermutator gliomas.
58. Gliomatosis Cerebri: Predispositions and Predictors of Behavior (P6.152)
59. Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma (GBM) Patients
60. PATH-37. THE NATURAL COURSE OF HYPERMUTATOR GLIOMAS
61. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
62. Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105
63. Association of clinical phenotype and treatment history with survival in adult brainstem glioblastoma.
64. A Rare Case of Primary Angiitis of the Central Nervous System (PACNS) Associated with Metastatic Prostate Cancer (P3.155)
65. RARE-26. GLIOMATOSIS, TO BE OR NOT TO CEREBRI: AN EVALUATION OF HOST SYSTEMIC IMMUNE FACTORS THAT POTENTIALLY PREDISPOSE TO DIFFUSE INFILTRATIVE GLIOMA PATTERNS
66. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
67. Gliomatosis, to Be or Not to Cerebri? (P6.299)
68. ATNT-20A PHASE I-II TRIAL EVEROLIMUS AND SORAFENIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: BRAIN TUMOR TREATMENT COLLABORATIVE TRIAL 09-01
69. Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105.
70. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the CNS
71. Phase I study of vorinostat combined with isotretinoin and temozolomide in adults with recurrent malignant gliomas.
72. A phase I trial everolimus and sorafenib in patients with recurrent high-grade gliomas: Brain Tumor Treatment Collaborative trial 09-01.
73. Outcomes after hospitalization in patients with recurrent glioblastoma.
74. Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial
75. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
76. Intraventricular tobramycin for bacterial meningitis (P5.115)
77. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
78. Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors.
79. Leptomeningeal disease and breast cancer: Relationship of outcome and subtype.
80. Quality of life (QOL) and cognitive status among irradiated brain tumor survivors treated with donepezil or placebo.
81. Phase I lead-in to a 2x2x2 factorial trial of dose-dense temozolomide, memantine, mefloquine, and metformin as postradiation adjuvant therapy of glioblastoma (GBM).
82. BTTC08-01: A phase II study of bevacizumab and erlotinib after radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation.
83. Prolonged Survival in Adult Patients with Neurofibromatosis Type I and Recurrent High Grade Gliomas Treated with Bevacizumab (P01.098)
84. Lenalidomide and irinotecan in adults with recurrent malignant gliomas: Phase I results of the phase I/II trial.
85. Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
86. Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study
87. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
88. ATIM-07. WINDOW-OF-OPPORTUNITY CLINICAL TRIAL OF PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS.
89. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.